A股再添百亿美元BD大单,创新药“青苗”出海引担忧

投资有道杂志
Jul 31

近日,恒瑞医药再添海外BD(商务拓展)大单,首付款多达5亿美元,里程碑付款的潜在总金额约120亿美元。不过,在国产创新药海外BD密集落地的背后,“卖青苗”的忧虑声也在业内流传。来源:摄图网恒瑞医药BD交易再添百亿美元大单7月28日盘前,恒瑞医药(600276.SH,01276.HK)公告披露,公司与交易方GSK(葛兰素史克)达成协议,公司将HRS-9821项目的全球独家权利(不包括中国地区)和至多...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10